Adial Pharmaceuticals, Inc - Common Stock — Quarterly Cash Flow (NASDAQ:ADIL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 3.45 M6.8 M5.66 M6.67 M5.23 M Total liabilities 1.32 M1.21 M1.15 M1.4 M1.51 M Total equity 2.13 M5.59 M4.51 M5.28 M3.72 M Total liabilities & shareholders' equities 3.45 M6.8 M5.66 M6.67 M5.23 M Total debt ————— Net debt —————

News

Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals signs framework deal with Molteni for Europe

EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals stock rises on FDA policy shift

Adial Pharmaceuticals eyes single pivotal trial path for AD04

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com

Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split

Adial Pharmaceuticals announces 1-for-25 reverse stock split

Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr.

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Adial Pharmaceuticals raises $2.86 million through warrant exercise

Adial completes key validation for alcohol disorder treatment test